Lipton et al. indicated that the protein expression level of HER3 could be used to define multiple subtypes of HER2-positive breast cancer, indicating the important but limited involvement of HER3 alone as a marker in breast cancer [4]. The gene discussed is ERBB2; the disease is breast carcinoma.